Neudle.com: multifocal leucoencephalopathy progressive

Differential
(Click to cross reference)

abscess, intracerebral

abulia

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acquired immunodeficiency syndrome, congenital

acquired immunodeficiency syndrome, heralded by neurologic invol

acquired immunodeficiency syndrome, infants and children

acquired immunodeficiency syndrome-related complex

acute disseminated encephalomyelitis

acute necrotizing encephalitis

adrenoleukodystrophy

advances in neurology

adverse drug reaction

alcohol, neurologic complications with

amyloid angiopathy, cerebral

amyloidosis

ANA

anergy

angiitis, granulomatous of CNS

angiitis, isolated of CNS

angiotensin-converting enzyme

anti DNA agent

anti JC virus antibodies

antibiotics

anticonvulsants, untoward effects of

arteriovenous malformation

arteriovenous malformation, cerebral

atlanto-axial subluxation

basal ganglia, lesion of

basal ganglia, lesion, bilateral

bone marrow transplantation

bradyphrenia

brain biopsy

brain biopsy, complications of

brain biopsy, false negative

brain biopsy, indication

brain biopsy, negative

brain biopsy, stereotaxic

brainstem

brainstem, hemorrhage, primary

brainstem, infarction of

brainstem, lesion of

brentuximab

brucellosis, nervous system involvement with

Brudzinski's sign

busulfan

cachexia

calcification, intracranial

calculations

Canavan's disease

candida albicans

carbon monoxide poisoning

carcinoma

cardiac transplantation

carphology

CAT scan

CAT scan, abnormal

CAT scan, contrast enhanced

CAT scan, contrast enhanced, delayed

CAT scan, demyelinating disease

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, mass effect on

CAT scan, serial

cause of death

CD4 counts

celiac disease, adult

central nervous system, infection of

central nervous system, infection, cancer patient

central pontine myelinolysis

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar hemorrhage

cerebellar lesion

cerebellar peduncle

cerebellum

cerebellum, disease of

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortex

cerebral cortical atrophy

cerebral infarction

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, cell count, normal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, gold sol.curve of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, pressure increased

cerebrovascular accident

cerebrovascular accident, mimics

cerebrovascular accident, misdiagnosis

cerebrovascular accident, secondary prevention

cerebrovascular disease

chemotherapy, CNS treatment and complications with

chest x-ray, abnormal

Clinical Pathologic Conference(C.P.C.)

coccidioidomycosis

coinfection

collagen vascular disease

Collier's sign

common variable immunodeficiency

complications

compression neuropathy

concentric sclerosis

confabulation

confusion

confusional state, acute

congenital infection, viral

controversies in neurology

cop 1

corpus callosum

corpus callosum, infarction of

corpus callosum, lesion of

corpus callosum, neoplasm of

cortical blindness

cost effectiveness

cranial nerve palsies

cranial nerves

cranial neuropathy

cranial neuropathy, multiple

creatine phosphokinase(CPK)elevated

cryptococcal meningitis

cryptococcoma, cerebral

cryptococcosis

cyclosporine

cytomegalovirus infection

dementia, differential diagnosis of

demyelinating disease

differential diagnosis

diffuse axonal injury

disability rating scale, neurological

disability, neurological

disorientation

disseminated intravascular coagulation(DIC)

DNA probes

drug abuse

drug abuse, neurologic complications of

drug holiday

drug induced neurologic disorders

drug withdrawal

dural rheumatoid nodules

electroencephalogram, abnormalities of

electron microscopy

encephalitis

encephalitis, brainstem

encephalitis, focal

encephalitis, human immunodeficiency virus type 1

encephalitis, paraneoplastic

encephalitis, viral

encephalomyelitis

encephalomyelitis, postinfectious

encephalopathy

encephalopathy, metabolic

endocarditis, marantic

epidemiology of neurology

Epstein-Barr virus

escherichia coli

etanercept

evidence-based research

evoked potentials

experimental allergic encephalitis

finger nose finger test

fingolimod

fluorescent treponema antibody absorption/false positive

frontal lobe, behavior with disease of

fundus, abnormality of

fungal infection, CNS

gadolinium

gait disorder

gammaglobulin therapy, intravenous

gaze palsy

gaze palsy, horizontal

gaze palsy, vertical

genetic neurologic disorders

genu of corpus callosum

glioblastoma multiforme(astrocytoma Gr.III)

gliomatosis cerebri

gram negative rod

granulomatous disease

gray matter

Guillain Barre syndrome

gumma

hallucination

hallucination, visual

hemianopia, homonymous

hemiparesis

hemiplegia

hemiplegia, progressive

hepatomegaly

hepatosplenomegaly

heralding manifestation

herpes simplex encephalitis

herpes simplex virus

herpes virus infection

herpes zoster

highly active antiretroviral therapy

human immunodeficiency virus type 1

human immunodeficiency virus type 1, pathogenesis

human immunodeficiency virus type 1, testing

hypertensive encephalopathy

hypoglycorrhachia

hypothalamus

hypothalamus, disturbance of

hypothalamus, lesion of

iatrogenic neurologic disorders

idiopathic CD4+lymphopenia

imbalance

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune reconstitution inflammatory syndrome, paradoxical

immune reconstitution inflammatory syndrome, unmasked

immune-related adverse events

immunocompetent

immunodeficiency

immunofluorescent exam of CSF cells

immunohistochemistry

immunologic disease

immunology and the nervous system

immunomodulation

immunoperoxidase staining

immunosuppression

immunosuppressive agents

immunotherapy

in situ hybridization

in situ polymerase chain reaction

incidence

inclusion bodies

inclusion bodies, intranuclear

incoordination

infection

infliximab

intellectual deterioration

interferon

interferon beta 1-a

interleukin 2

intracerebral hemorrhage

intracerebral hemorrhage, multiple

intracranial hypertension, benign

intravenous drug abuse

iododeoxyuridine

Jakob-Creutzfeldt disease

JC virus

JC virus cerebellar granule cell neuronopathy

JC virus encephalopathy

Karnofsky performance scale

Kernig's sign

Korsakoff's psychosis

leg weakness, bilateral

lethargy

leukemia

leukemia, neurologic findings assoc.with

leukodystrophy

leukoencephalitis, acute necrotizing hemorrhagic

leukoencephalopathy

leukoencephalopathy, differential diagnosis

leukoencephalopathy, toxic

leukostasis

levamisole

level of consciousness, decreased

life expectancy

limbic encephalitis

lipoma of CNS

listeria monocytogenes

listeriosis, CNS

liver transplantation

lymphadenopathy, hilar

lymphocytic interstitial pneumonitis

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

lymphopenia

malabsorption syndrome

malformation, vascular, cerebral

Marchiafava-Bignami disease

medication withdrawal

memory, defect of recent

memory, impairment of

meningeal enhancement

meningismus

meningitis

meningitis, aseptic

meningitis, bacterial

meningitis, cancer patients with

meningitis, carcinomatous

meningitis, chronic

meningitis, CSF cell count-normal

meningitis, CSF findings in

meningitis, escherichia coli

meningitis, fungal

meningitis, leukemic

meningitis, lymphomatous

meningitis, predisposing factors in

meningitis, pseudomonas

meningitis, spinal fluid smear and culture of

meningitis, TB

meningoencephalitis

meningoencephalitis, amoebic

meningoencephalitis, mumps

mental status, abnormal

metachromatic leukodystrophy

microaneurysm, retinal

midbrain

midbrain, lesion of

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebellar peduncle, lesion, bilateral

migraine

mimics

misdiagnosis

mitochondrial disease

mitral valve vegetation

monoclonal antibodies

mononeuritis multiplex

mononeuropathy

mononeuropathy multiplex

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, ADC maps

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion tensor

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, FLAIR

MRI, high signal foci on

MRI, magnetization transfer sequence

MRI, mass effect on

MRI, negative

MRI, punctate pattern

multiple sclerosis, acute

multiple sclerosis, diagnosis of

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, etiology of

multiple sclerosis, misdiagnosis

multiple sclerosis, relapsing

multiple sclerosis, treatment of

neoplasm, primary intracerebral

neoplasm, primary of CNS

neoplasm, primary of CNS-multiple

neoplasm, second primary

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multiple

neurologic signs

neurologic symptoms

neuromyelitis optica (Devic's disease)

neuropathology

neuropathology, brain

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, peripheral

neuropathy, peripheral, treatment

opportunistic infection

opportunistic infection, CNS

organ transplantation

osmotic demyelination syndrome

parasitic infection, CNS

pathology

pembrolizumab

pericarditis

peripheral nerve, lesion of

pituitary, metastasis to

plasmapheresis

plasmapheresis, complications of

pleocytosis of cerebrospinal fluid

pneumonia

polymerase chain reaction

polymerase chain reaction, false negative

polymerase chain reaction, false positive

polymyositis

polyneuropathy

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

posterior fossa

posterior fossa, lesion of

posterior inferior cerebellar artery syndrome

posterior leukoencephalopathy syndrome

practice guidelines

preclinical

pregnancy, neurologic complications in

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive multifocal leukoencephalopathy, etiology

progressive neurologic disorder

protease inhibitor, HIV-1

proteus mirabilis

pseudomonas aeruginosa

psoriasis

psychiatric problems in neurologic disorders

psychomotor retardation

psychosis

pulmonary infiltrates

quadriparesis

quality of life

radiation therapy, CNS treatment and complications with

radiculitis

regional enteritis

release phenomena

remote effect of cancer on the nervous system

renal failure

renal stones

renal transplantation

rheumatoid arthritis, neurologic complications of

rheumatoid pachymeningitis

risk factors

risk stratification

risk-benefit assessment

shunt procedure, ventricular

shunt procedure, ventricular-complications of

single photon emission computed tomography

single photon emission computed tomography, thallium

skin, lesions in neurologic disorders

skull x-ray

skull x-ray, abnormal

slow virus infection of CNS

spinal cord, compression of

spinal cord, lesion of

splenectomy

splenomegaly

spongy degeneration of brain

status epilepticus

stem cell transplantation

steroid

steroid therapy, CNS treatment and complications with

stroke center

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subarachnoid hemorrhage

subcortical U fibers

subcutaneous nodules

subdural hematoma

symmetric brain lesions

syphilis, diagnosis and treatment

syphilis, neurologic complications with

systemic illness

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

toxoplasmosis, acquired

toxoplasmosis, CNS

toxoplasmosis, prophylaxis

transient ischemic attack

treatment of neurologic disorder

tremor

tremor, rubral

trigeminal neuropathy

tuberculoma of CNS

tuberculosis

tumor necrosis factor inhibitor

upgaze

uveitis

vaccination, neurologic complications with

vaccine

varicella zoster virus

varicella zoster virus, encephalitis

vasculitides

vasculopathy

ventriculitis

vincristine neurotoxicity

viral infection

viral infection, CNS

viral infection, CNS, treatment of

viral infection, reactivation

visual acuity, decreased

weakness, progressive

weight loss

Whipple's disease

white matter disease

white matter disease, subcortical

white matter, dirty-appearing

wide based gait

Wiskott-Aldrich syndrome

workup

Showing articles 200 to 250 of 3460 << Previous Next >>

Whipple's Disease-Dementia
ed. by Charles G. Wells, Chap. 10 by Gunther Haas-Contemporary Neuro. Series 192, 1971 Published by, . A. Davila., 1971

Progress Toward Mitigating Disability Progression in Multiple Sclerosis
NEJM 392:1966-1968, Calabresi,P.A., 2025

Slowly Expanding Lesions Differentiate Pediatric Multiple Sclerosis from Myelin Oligodendrocyte Glycoprotein Antibody Disease
Ann Neurol 96:1086-1091, Fadda,G.,et al, 2024

A Young Woman with Rapidly Progressive Weakness and Paresthesia
Neurol 101:676-681, Alwakeel,S.S.,et al, 2023

Telemedicine in Neurology
Neurol 94:30-38,16, Hatcher-Martin, J.M.,et al, 2020

A 65-year-old man with Asymmetric Weakness and Parethesias
Neurol 93:856-861, Harada, Y.,et al, 2019

A Middle-Aged Man with New Onset Seizures and Myoclonic Jerks
Neurol 92:e274-e281, Chen, Z. & Neo, S., 2019

Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis
JAMA 32:175-187, Brown, J.W.L.,et al, 2019

Multiple Sclerosis
NEJM 378:169-180, Reich, D.S.,et al, 2018

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
NEJM 376:209-220,280, Montalban, X.,et al, 2017

Clinicopathologic Conference, Granulomatous Amebic Encephalitis and Sarcoidosis (Inactive)
NEJM 376:368-379, Case 3-2017, 2017

Cranial Nerve Hypertrophy in IgG4 Anti-Neurofascin 155 Antibody-Positive Polyneuropathy
Neurol 88:e52, Franques, J.,et al, 2017

Long-Term Outcomes after Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
JAMA Neurol 74:459-469,392, Muraro, P.A.,et al, 2017

Clemastine Fumarate as a Remyelinating Therapy for Multiple Sclerosis (ReBUILD): A Randomised, Controlled, Double-Blind, Crossover Trial
Lancet 390:2481-2489, Green, A.J.,et al, 2017

A 37-Year-Old Man with Multiple Cranial Neuropathies
Neurol 86:e66-e70, OLoghlen, S.,et al, 2016

Longitudinally Extensive Spinal Cord Lesions Disclosing Occult Systemic Sarcoidosis
JAMA Neurol 73:600-601, Sechi, E.,et al, 2016

Responsibilities of Health Care PRofessionals in Counseling and Educating Patients with Incurable Neurological Diseases Regarding "Stem Cell Tourism"
JAMA Neurol 72:1342-1345, Bowman, M.,et al, 2015

Palliative Care and Neurology
Neurol 83:561-567, Boersma, I.,et al, 2014

IgG4-Related Leptomeningitis: A Reversible Cause of Rapidly Progressive Cognitive Decline
Neurol 82:540-542, Mehta, S.H.,et al, 2014

Central Nervous System Manifestation of IgG4-Related Disease
JAMA Neurol 71:767-770, Regrev, K.,et al, 2014

Paraneoplastic Neurological Syndromes
Clin Exp Immunol 175:336-348, Leypoldt, F. & Wandinger, K.-P., 2014

Interferon beta for Secondary Progressive Multiple Sclerosis: A Systematic Review
JNNP 84:420-426, La Mantia, L.,et al, 2013

Characterising Aggressive Multiple Sclerosis
JNNP doi:10.1136 1-7, Menon, S.,et al, 2013

Solitary Sclerosis
Neurol 78:540-544, Schmalstieg,W.F.,et al, 2012

Progressive Weakness with Respiratory Failure in a Patient with Sarcoidosis
Arch Neurol 69:534-537, Chaudhry,P.,et al, 2012

Monosymptomatic Clinically Isolated Syndrome with Sudden Sensorineural Hearing Loss
The Neurologist 18:302-305, Anagnostouli, M.C.,et al, 2012

Demographic and Clinical Characteristics of Malignant Multiple Sclerosis
Neurol 76:1996-2001, Gholipour, T.,et al, 2011

Clinical Reasoning: A 34-year-old man with recurrent limb weakness
Neurol 77:e68-e72, Karam, C.,et al, 2011

Increased Tissue Damage and Lesion Volumes in African Americans with Multiple Sclerosis
Neurol 74:538-544,532, Weinstock-Guttman,B.,et al, 2010

Diffusely Abnormal White Matter in Progressive Multiple Sclerosis: In Vivo Quantitative MR Imaging Characterization and Comparison between Disease Types
AJNR 31:541-548, 390, Vrenken,H.,et al, 2010

Diffusely Abnormal White Matter in Chronic Multiple Sclerosis: Imaging and Histopathologic Analysis
Arch Neurol 66:601-609, Seewann,A.,et al, 2009

Cortical Lesions in Primary Progressive Multiple Sclerosis: A 2-Year Longitudinal MR Study
Neurol 72:1330-1336, Calabrese,M.,et al, 2009

What Are the Prospects of Stem Cell Therapy for Neurology?
BMJ 337:1325-1327, Chandran,S., 2008

Rapidly Progressive Dementia
Ann Neurol 64:97-108, Geschwind,M.D.,et al., 2008

Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis
Arch Neurol 65:1044-1051, Krishnan,C.,et al., 2008

Combining Beta Interferon and Atorvastatin May Increase Disease Activity in Multiple Sclerosis
Neurol 71:1390-1395,1386, Birnbaum,G.,et al, 2008

Acute Fulminant Demyelinating Disease: A Descriptive Study of 60 Patients
Arch Neurol 64:1426-1432, de Seze,J.,et al, 2007

How Effective Are Disease-Modifying Drugs in Delaying Progression in Relapsing-Onset MS?
Neurol 69:1498-1507, Brown,M.G.,et al, 2007

Effect of Mitoxantrone on MRI in Progressive MS, Results of the MIMS Trial
Neurol 65:690-695, Krapf,H.,et al, 2005

Angiography-Negative Primary Central Nervous System Vasculitis in Children
Arthritis Rheum 52:2159-2167, Benseler, S.M.,et al, 2005

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1779-1787,1768, Kappos,L.,et al, 2004

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1788-1795,1768, The North American Study Group on Interferon beta-, 2004

Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004

Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004

Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis: Randomised Placebo-Controlled Trial
Lancet 364:1149-1156, Hommes,O.R.,et al, 2004

The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis
Neurol 61:1332-1338, Goodin,D.S.,et al, 2003

Spinal Cord Biopsy: A Review of 38 Cases
Neurosurgery 52:806-816, Cohen-Gadol,A.A.,et al, 2003

Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002

Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002

Assessment of Normal-Appearing White and Gray Matter in Patients with Primary Progressive Multiple Sclerosis
Arch Neurol 59:1406-1412, Rovaris,M.,et al, 2002

Showing articles 200 to 250 of 3460 << Previous Next >>